Norway· NO-ID_131B5F23-3351-45E9-B029-FDA5493A4782
Hylase dessau
A hyaluronidase product containing hyaluronidase, registered in Norway by Esteve Pharmaceuticals GmbH. The same ATC class is registered in 7 of our 19 countries.
Checked against FEST (Norway) on
Informational only — not a medical device.
Where it is registered
Hyaluronidase is registered in 7 of 19 countries.
Countries holding a registration under ATC B06AA03 (hyaluronidase), each read from that country’s own register.
- This record: Norway, from FEST (Norway)
- 3 of them publish a price we can compare per daily dose
Hyaluronidase · ATC B06AA03
7 / 19 countries
- Finlandprice
- Germany
- Ireland
- Netherlands
- Norwayprice
- United Kingdom
- United Statesprice
The record
At a glance
FEST (Norway)- Active substance
- Hyaluronidase
- Manufacturer
- Esteve Pharmaceuticals GmbH
- Country
- Norway (NO)
- ATC code
- B06AA03
- ATC class
- Hyaluronidase
- Reimbursed
- Not published by this register
- Source register
- FEST (Norway)
- Last checked
- September 25, 2026
Packs & prices · 3
- no_merkevare_idID_131B5F23-3351-45E9-B029-FDA5493A4782
- no_varenummer23206110 x 150
- gtin4150067856341
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
84 interactions on record for hyaluronidase.
Graded by severity as the source publishes them — 84 minor. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Hyaluronidase · interactions on record
84 records
Same medicine, other countries
Hyaluronidase in 5 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomHyalase 1500unit powder for solution for injection ampoulesWockhardt UK Ltd
- GermanyHylase „dessau“Esteve Pharmaceuticals Gmbh
- IrelandHyaluronidase 1500 I.U. Powder for Solution for Injection or InfusionPinewood Laboratories Ltd
- NetherlandsHyason 150 I.E., poeder voor injectievloeistofEsteve Pharmaceuticals GmbH
- United StatesAMPHADASEAmphastar Pharmaceuticals, Inc.
Authorised across Europe · EMA
The same active substance is authorised in 6 EEA countries. Names it is sold under:
- Austria · Hylase Dessau
- Germany · Hylase Dessau
- United Kingdom (Northern Ireland) · Hyalase, Hyaluronidase Wockhardt Uk
- Ireland · Hyaluronidase Pinewood Laboratories
- Malta · Hyalase
- Netherlands · Hyason
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FEST (Norway). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/f5d59e84-4175-43ef-8471-bbc6a9fb7931 GET /v1/drugs/f5d59e84-4175-43ef-8471-bbc6a9fb7931?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Pulver til injeksjonsvæske, oppløsning",
"source": "fest",
"status": "A",
"atc_name": "Hyaluronidase",
"merkevare_id": "ID_131B5F23-3351-45E9-B029-FDA5493A4782",
"name_form_strength": "Hylase dessau pulv til inj væske, oppl 150 IE",
"prescription_group": "C"
}See everything about hyaluronidase.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.